Teva Pharmaceutical Industries shares owned by Hartford Investment Management Company
Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Hartford Investment Management Company
from 13F filings
Historical chart of Hartford Investment Management Company investment in Teva Pharmaceutical Industries
Tip: Access up to 7 years of quarterly data
All positions including Teva Pharmaceutical Industries held by Hartford Investment Management Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Teva Pharmaceutical Industries by Hartford Investment Management Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $233k | 11k | 22.04 |
| 2024-09-30 | $190k | 11k | 18.02 |
| 2024-06-30 | $171k | 11k | 16.25 |
| 2024-03-31 | $146k | 10k | 14.11 |
| 2023-12-31 | $108k | 10k | 10.44 |
| 2023-09-30 | $105k | 10k | 10.20 |
| 2023-06-30 | $76k | 10k | 7.53 |
| 2022-06-30 | $98k | 13k | 7.54 |
| 2022-03-31 | $122k | 13k | 9.37 |
| 2021-12-31 | $161k | 20k | 8.01 |
| 2021-09-30 | $198k | 20k | 9.76 |
| 2021-06-30 | $231k | 23k | 9.90 |
| 2021-03-31 | $274k | 24k | 11.53 |
| 2020-12-31 | $253k | 26k | 9.64 |
| 2020-09-30 | $236k | 26k | 8.99 |
| 2020-06-30 | $332k | 27k | 12.32 |
| 2020-03-31 | $240k | 27k | 8.98 |
| 2019-12-31 | $258k | 26k | 9.81 |
| 2019-09-30 | $192k | 28k | 6.90 |
| 2019-06-30 | $261k | 28k | 9.21 |
| 2019-03-31 | $417k | 27k | 15.69 |
| 2018-12-31 | $456k | 30k | 15.42 |
| 2018-09-30 | $618k | 29k | 21.55 |
| 2018-06-30 | $725k | 30k | 24.31 |
| 2018-03-31 | $480k | 28k | 17.10 |
| 2017-12-31 | $588k | 31k | 18.93 |
| 2017-09-30 | $548k | 31k | 17.59 |
| 2017-06-30 | $1.1M | 32k | 33.21 |
| 2017-03-31 | $1.1M | 35k | 32.09 |
| 2016-12-31 | $1.7M | 47k | 36.25 |
More positions owned by Hartford Investment Management Company
View all positions for Hartford Investment Management Company
Top funds holding Teva Pharmaceutical Industries
View all funds holding Teva Pharmaceutical Industries